Delivery Order SPE2DB20D2002-SPE2DB25FL21N

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,282.76 and a completion date of September 26, 2024. It is a Firm Fixed Price, Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.67 firm-fixed-price delivery order is for the supply of ATOMOXETINE HCL 10 MG CAPSULES, with a completion date of November 8, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.16 firm fixed-price delivery order is for the supply of 4556432935 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
This federal contract award, valued at $1,035.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564675659 ! ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. This is a Firm Fixed Price Delivery Order contract with a completion date of May 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4564460088 - ATOMOXETINE HCL 40 MG CAPSULE 30S, a specialty medication, with a ceiling value of $1,624.36 and a performance period through May 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB22FU1B2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,014.30 firm fixed-price delivery order is for the supply of 4557922882 - ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The award is not associated with a set-aside program and has an ultimate completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $1,292.40 fixed-price delivery order is for the supply of 4564350703 - ATOMOXETINE HCL 40 MG CAPSULE 30S, with a completion date of April 23, 2024. Amerisourcebergen holds two larger Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...
This is a $1,766.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4562876774 ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order (SPE2DX24F1VUX) for the supply of 4565573039 - ATOMOXETINE HCL 10 MG CAPSULE 30S. The $1,090.47 firm fixed price contract has an ultimate completion date of August 27, 2024 and was awarded on August 26, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is not set aside for any specific business type. As a large distributor of pharmaceutical products...
This federal contract award, with an ID of SPE2DB22D3102|SPE2DB24FL1CQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564591314 - ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $1,064.74 and a completion date of May 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB25FL21N
    Delivery Order

This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL21N, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,281.94 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S, a type of prescription medication. The contract has an ultimate completion date of February 21, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:07 PM